Status:
UNKNOWN
To Assess the Efficacy of the LYMPHA in the Prevention of Lymphedema Following Axillary Dissection for Breast Cancer
Lead Sponsor:
Pusan National University Hospital
Conditions:
Lymphedema, Breast Cancer
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
Lymphedema is the Build-up of Lymph Fluid in the Body's Tissue Causing Chronic, Debilitating Swelling. This Commonly Occurs as a Result of a Disruption of the Lymphatic System During Lymph Node Dissec...
Detailed Description
Consenting patients will have the LYMPHA procedure at the time of planned axillary dissection surgery for the prevention of upper and extremity lymphedema. The node dissection will be performed by Dr....
Eligibility Criteria
Inclusion
- Node-positive cancer requiring an axillary or lymphadenectomy
- Below 30 Body Mass Index
Exclusion
- Patients receiving a sentinel lymph node biopsy
- Patients with established preoperative lymphedema
- Patients with post-thrombotic syndrome, peripheral vascular disease
- Pregnant patients
Key Trial Info
Start Date :
March 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04328610
Start Date
March 5 2020
End Date
February 28 2022
Last Update
March 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan National University Hospital
Busan, Seo-Gu, South Korea, 49241